These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9870978)
21. Changes in mouse brain neurotensin receptor density following chronic infusion of neurotensin. Campbell AD; Erwin VG Peptides; 1995; 16(3):501-4. PubMed ID: 7651905 [TBL] [Abstract][Full Text] [Related]
22. Neurotensin Attenuates Nociception by Facilitating Inhibitory Synaptic Transmission in the Mouse Spinal Cord. Zhang MM; Feng YP; Qiu XT; Chen T; Bai Y; Feng JM; Wang JD; Chen Y; Zhang MZ; Duan HK; Zhao M; Teng YH; Cao J; Zang WD; Yang K; Li YQ Front Neural Circuits; 2021; 15():775215. PubMed ID: 35002634 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities. Lundquist JT; Büllesbach EE; Dix TA Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946 [TBL] [Abstract][Full Text] [Related]
24. Improvement in blastocyst quality by neurotensin signaling via its receptors in bovine spermatozoa during in vitro fertilization. Umezu K; Yajima R; Hiradate Y; Yanai R; Numabe T; Hara K; Oikawa T; Tanemura K J Reprod Dev; 2019 Apr; 65(2):147-153. PubMed ID: 30662011 [TBL] [Abstract][Full Text] [Related]
25. Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue. Martin S; Vincent JP; Mazella J J Cell Sci; 2002 Jan; 115(Pt 1):165-73. PubMed ID: 11801734 [TBL] [Abstract][Full Text] [Related]
27. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio. Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956 [TBL] [Abstract][Full Text] [Related]
28. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294 [TBL] [Abstract][Full Text] [Related]
29. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia. Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400 [TBL] [Abstract][Full Text] [Related]
30. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Martin S; Botto JM; Vincent JP; Mazella J Mol Pharmacol; 1999 Feb; 55(2):210-5. PubMed ID: 9927610 [TBL] [Abstract][Full Text] [Related]
31. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Dubuc I; Costentin J; Terranova JP; Barnouin MC; Soubrié P; Le Fur G; Rostène W; Kitabgi P Br J Pharmacol; 1994 Jun; 112(2):352-4. PubMed ID: 8075852 [TBL] [Abstract][Full Text] [Related]
32. Low doses of neurotensin in the preoptic area produce hyperthermia. Comparison with other brain sites and with neurotensin-induced analgesia. Benmoussa M; Chait A; Loric G; de Beaurepaire R Brain Res Bull; 1996; 39(5):275-9. PubMed ID: 8705314 [TBL] [Abstract][Full Text] [Related]
34. The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells. Sicard F; Contesse V; Lefebvre H; Ait-Ali D; Gras M; Cartier D; Decker A; Chartrel N; Anouar Y; Vaudry H; Delarue C J Clin Endocrinol Metab; 2006 Aug; 91(8):3131-7. PubMed ID: 16705076 [TBL] [Abstract][Full Text] [Related]
35. Comparison of neurotensin levels, receptors and actions in LS/Ibg and SS/Ibg mice. Erwin VG; Jones BC Peptides; 1989; 10(2):435-40. PubMed ID: 2547208 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological heterogeneity of neurotensin receptors: an in vitro study. Nguyen-Le XK; Neugebauer W; Gobeil F; Pheng LH; Nsa Allogho S; Regoli D Can J Physiol Pharmacol; 1997 Jun; 75(6):547-51. PubMed ID: 9276126 [TBL] [Abstract][Full Text] [Related]
37. Expression of neurotensin receptors in human corneal keratocytes. Bourcier T; Rondeau N; Paquet S; Forgez P; Lombet A; Pouzaud F; Rostène W; Borderie V; Laroche L Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1765-71. PubMed ID: 12036977 [TBL] [Abstract][Full Text] [Related]
38. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain. Smith KE; Boules M; Williams K; Richelson E Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145 [TBL] [Abstract][Full Text] [Related]
39. A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist. Cusack B; Jansen K; McCormick DJ; Chou T; Pang Y; Richelson E Biochem Pharmacol; 2000 Sep; 60(6):793-801. PubMed ID: 10930533 [TBL] [Abstract][Full Text] [Related]
40. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Sahu A; Carraway RE; Wang YP Brain Res; 2001 Jan; 888(2):343-347. PubMed ID: 11150496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]